ma.balogun
TL2 Moderator · Aarhus
Contributes reviews on supplier material. Based in Aarhus.
Joined 29 December 2024 · last posted 21h
85 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #75 · Access › Insurance & coverage · 27 Jul 2026 · 0 likes On post #71 — agreed on the reasoning, with one qualification. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #111 · Analytics › Home & field testing · 22 Jul 2026 · 24 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Here for the analytics and not much else Replied, post #54 · Lounge › Introductions · 18 Jul 2026 · 1 like No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
-
What a reversed-phase purity number actually is Replied, post #67 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 32 likes Worth separating two things that post #63 runs together. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #93 · Analytics › Method validation · 17 Jul 2026 · 0 likes Coming back to post #91, because the follow-up matters more than the original answer. Specificity: the method can distinguish the intended compound from related…
-
What to include when your question involves a chromatogram — one year on Replied, post #70 · Start Here › How to Ask · 9 Jul 2026 · 0 likes On post #66 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Batch numbers that do not match the vial label Replied, post #39 · Sourcing › Red flags · 6 Jul 2026 · 32 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Dizziness on standing: the ordinary explanation first — one year on Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 4 Jul 2026 · 3 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Common supplements people ask about, assessed one at a time Replied, post #7 · Practice › Interactions · 3 Jul 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
How to disagree with an answer you were given, well Replied, post #12 · Start Here › How to Ask · 20 Jun 2026 · 0 likes Picking up post #9: that is the part I would want checked first. What you have already read matters. Saying "I read the maintained page on this and I still have a gap"…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #41 · Analytics › Home & field testing · 3 Jun 2026 · 3 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Follow-up: Interpreting a composition change that is within the error bars Replied, post #2 · Outcomes › Body composition · 28 May 2026 · 23 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #98 · Compounds › Tirzepatide · 28 May 2026 · 17 likes Coming back to post #96, because the follow-up matters more than the original answer. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
-
Does a peptide degrade silently, with no visual change? Replied, post #30 · Practice › Storage & stability · 19 May 2026 · 19 likes post #29 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #70 · Data & Tools › Calculators · 6 May 2026 · 0 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #13 · Analytics › Method validation · 3 May 2026 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
[2026 update] What a purity-only report leaves out Replied, post #103 · Sourcing › Independent verification · 24 Apr 2026 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #16 · Sourcing › Logistics · 21 Apr 2026 · 28 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
The headache that turns out to be dehydration — the long version Replied, post #21 · Nutrition & Training › Hydration & electrolytes · 13 Apr 2026 · 0 likes post #20 answers the question as asked. The question underneath it is different. Potassium: similar to sodium; losing weight involves some potassium loss. Bananas,…
-
Endotoxin and why it is a separate question from purity Replied, post #3 · Analytics › Impurities & related substances · 11 Apr 2026 · 7 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #11 · Pharmacology › Pharmacokinetics · 10 Apr 2026 · 22 likes Worth separating two things that post #7 runs together. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #56 · Evidence › Trials · 4 Apr 2026 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #21 · Evidence › Journal club · 1 Apr 2026 · 18 likes Worth separating two things that post #17 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Spreadsheets: an appreciation — what changed since Replied, post #6 · Lounge › Off topic · 25 Mar 2026 · 0 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
Five questions in one post gets you one answer — how to split them Replied, post #34 · Start Here › How to Ask · 18 Mar 2026 · 3 likes post #33 is right about the mechanism and I think understates the practical bit. Context that matters: compound, how long in, current dose, relevant history. Context…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #3 · Practice › Side effects · 12 Mar 2026 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #33 · Sourcing › Vendor reports · 9 Mar 2026 · 24 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
The lowest dose that does anything: is that a real question? Replied, post #54 · Practice › Dosing & titration · 5 Mar 2026 · 2 likes This follows post #51 rather than contradicting it. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #30 · Compounds › Tirzepatide · 1 Mar 2026 · 10 likes post #29 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Started this topic · Practice › Dosing & titration · 28 Feb 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against — setting out what I have, and where I think it stops being reliable. I have read the maintained…
-
Angle of injection and whether 90 degrees is always right Replied, post #104 · Practice › Administration · 21 Feb 2026 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #50 · Practice › Reconstitution · 20 Feb 2026 · 21 likes post #49 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #9 · Analytics › Impurities & related substances · 20 Feb 2026 · 25 likes I read post #7 twice before replying, because I had assumed the opposite. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #82 · Practice › Dosing & titration · 19 Feb 2026 · 5 likes Picking up post #79: that is the part I would want checked first. How the published trials escalated: they used specific step sizes and intervals. The STEP programme…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #24 · Evidence › Study critique · 3 Feb 2026 · 9 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #22 · Sourcing › Independent verification · 29 Jan 2026 · 0 likes post #21 answers the question as asked. The question underneath it is different. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #20 · Practice › Interactions · 17 Jan 2026 · 19 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Research-use-only labelling: what it means and what it does not Replied, post #73 · Sourcing › Regulatory · 15 Dec 2025 · 19 likes Coming back to post #71, because the follow-up matters more than the original answer. Research-use-only status is a legal classification, not a safety classification.…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #12 · Compounds › Oral incretins · 14 Dec 2025 · 2 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #41 · Sourcing › Independent verification · 13 Dec 2025 · 6 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #11 · Practice › Interactions · 27 Nov 2025 · 18 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #32 · Compounds › Other compounds · 23 Nov 2025 · 22 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #7 · Compounds › Tirzepatide · 20 Nov 2025 · 0 likes This follows post #4 rather than contradicting it. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The…
-
[2026 update] What steady state means for the decision to escalate Replied, post #24 · Practice › Dosing & titration · 7 Nov 2025 · 2 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Temperature loggers worth the money Replied, post #51 · Devices › Cold chain · 6 Nov 2025 · 0 likes Picking up post #48: that is the part I would want checked first. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #10 · Practice › Storage & stability · 11 Oct 2025 · 5 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
The headache that turns out to be dehydration Started this topic · Nutrition & Training › Hydration & electrolytes · 15 Sep 2025 · 49 likes The headache that turns out to be dehydration Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss, which is…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #24 · Practice › Administration · 18 Aug 2025 · 0 likes Picking up post #21: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #5 · Evidence › Journal club · 7 Aug 2025 · 15 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #55 · Clinical › Special populations · 7 Aug 2025 · 6 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Injecting into an area that has become firm: why not to — does this still hold? Started this topic · Practice › Administration · 24 Jul 2025 · 9 likes Asking directly, because I could not find a straight answer: Injecting into an area that has become firm: why not to — does this still hold? I have read the maintained…
-
The C-cell question: rodent findings and their human context Replied, post #42 · Compounds › Semaglutide · 23 Jul 2025 · 5 likes On post #38 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Counter-ion content and its effect on measured mass Replied, post #96 · Analytics › Mass spectrometry · 19 Jul 2025 · 9 likes Resolution: "high resolution" commonly means
-
A field-by-field walk through a certificate of analysis Replied, post #44 · Analytics › COA interpretation · 15 Jul 2025 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Substitution between formats during a shortage Replied, post #23 · Access › Shortages · 15 Jul 2025 · 7 likes Picking up post #20: that is the part I would want checked first. Supply interruptions: official shortage notices are published by regulatory agencies. That is the…
-
Interim analyses and stopping rules — does this still hold? Replied, post #21 · Evidence › Trials · 30 Jun 2025 · 0 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #71 · Compounds › Retatrutide · 28 Jun 2025 · 0 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #71 · Clinical › Comorbidities · 21 Jun 2025 · 3 likes post #70 answers the question as asked. The question underneath it is different. Type 2 diabetes: the population with the largest evidence base for these compounds. The…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #18 · Practice › Dosing & titration · 16 Jun 2025 · 0 likes This follows post #15 rather than contradicting it. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #36 · Meta › Wiki maintenance · 14 Jun 2025 · 18 likes I read post #34 twice before replying, because I had assumed the opposite. Redundancy: if two maintained pages cover largely the same ground, consolidation might…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #89 · Practice › Reconstitution · 11 Jun 2025 · 1 like The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #30 · Compounds › Cagrilintide & amylin analogues · 7 Jun 2025 · 30 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Coming back to: Getting a referral rather than a refusal Replied, post #32 · Clinical › Prescriber conversations · 4 Jun 2025 · 3 likes Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #13 · Sourcing › Regulatory · 4 Jun 2025 · 25 likes post #12 is right about the mechanism and I think understates the practical bit. Off-label use and medical practice: clinicians can prescribe approved medications…
-
Follow-up: What other technical communities get right that we do not Replied, post #113 · Lounge › Off topic · 29 May 2025 · 30 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #6 · Compounds › Semaglutide · 26 May 2025 · 1 like post #5 is right about the mechanism and I think understates the practical bit. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #44 · Evidence › Journal club · 23 May 2025 · 11 likes Worth separating two things that post #40 runs together. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #45 · Sourcing › Independent verification · 23 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Storing a pen in use versus a pen unopened Replied, post #13 · Devices › Pens & autoinjectors · 12 May 2025 · 23 likes Picking up post #10: that is the part I would want checked first. Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #89 · Sourcing › Red flags · 2 May 2025 · 2 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Retatrutide dose escalation in the published trials Replied, post #112 · Compounds › Retatrutide · 10 Apr 2025 · 21 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #40 · Analytics › Mass spectrometry · 20 Mar 2025 · 19 likes I read post #38 twice before replying, because I had assumed the opposite. What mass accuracy establishes: the measured mass is consistent with a specific composition.…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #103 · Compounds › Semaglutide · 16 Mar 2025 · 1 like On post #99 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #89 · Sourcing › Regulatory · 3 Mar 2025 · 20 likes Worth separating two things that post #85 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #2 · Sourcing › Regulatory · 26 Feb 2025 · 0 likes This follows the opening post rather than contradicting it. Primary documents matter: regulatory positions are published in official documents. Reading the regulatory…
-
When "no data" is the complete and final answer Replied, post #77 · Compounds › Other compounds · 28 Jan 2025 · 3 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #121 · Access › Insurance & coverage · 14 Jan 2025 · 7 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #133 · Compounds › Repair & healing peptides · 24 Nov 2024 · 1 like Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #14 · Nutrition & Training › Protein & intake · 21 Nov 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #104 · Clinical › Prescriber conversations · 20 Nov 2024 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Requesting a page: what makes a good request — what changed since Replied, post #45 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #16 · Practice › Side effects · 25 Sep 2024 · 31 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #47 · Compounds › Semaglutide · 11 Sep 2024 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #10 · Nutrition & Training › Hydration & electrolytes · 23 Jul 2024 · 21 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
-
Cold packs, phase-change material, and what survives ten days Replied, post #88 · Sourcing › Logistics · 10 Jul 2024 · 3 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…